Trends in disease burden of type 2 diabetes, stroke, and hypertensive heart disease attributable to high BMI in China: 1990-2019.

Yunchao Wang, Junlin Jiang, Zhongxin Zhu
Author Information
  1. Yunchao Wang: Department of General Medicine, The First People's Hospital of Xiaoshan District, Xiaoshan Affiliated Hospital of Wenzhou Medical University, Hangzhou, Zhejiang, China.
  2. Junlin Jiang: Department of General Medicine, The First People's Hospital of Xiaoshan District, Xiaoshan Affiliated Hospital of Wenzhou Medical University, Hangzhou, Zhejiang, China.
  3. Zhongxin Zhu: Clinical Research Center, The First People's Hospital of Xiaoshan District, Xiaoshan Affiliated Hospital of Wenzhou Medical University, Hangzhou, Zhejiang, China.

Abstract

Background: High body mass index (BMI) is a significant risk factor for non-communicable diseases; however, its impact on disease burden in China remains understudied. This study aimed to analyze trends in the burden of type 2 diabetes mellitus (T2DM), stroke, and hypertensive heart disease (HHD) attributable to high BMI in China from 1990 to 2019.
Methods: We utilized data from the Global Burden of Disease 2019 study, quantifying disease burden through years lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life years (DALYs). Joinpoint regression analysis was employed to determine temporal trends.
Results: The study revealed distinct gender-specific temporal trends. Men exhibited a consistent increase in disease burden across all three conditions. Women showed more nuanced patterns: a gradual rise in T2DM burden, an inverted U-shaped trend for stroke, and a U-shaped trend for HHD in terms of age-standardized DALYs. Age-specific analysis demonstrated that the burden of T2DM and stroke peaked in the 70-74-year age group, whereas HHD-related DALYs continued to increase with advancing age.
Conclusions: Our findings underscore the need for tailored obesity prevention and management strategies in Chinese healthcare settings, emphasizing early screening and intervention for high BMI, particularly in middle-aged and older adults.

Keywords

References

  1. Nurs Clin North Am. 2021 Dec;56(4):527-541 [PMID: 34749892]
  2. Heart Fail Clin. 2019 Oct;15(4):509-517 [PMID: 31472886]
  3. J Hum Hypertens. 2022 Feb;36(2):126-134 [PMID: 34215840]
  4. Stat Med. 2000 Feb 15;19(3):335-51 [PMID: 10649300]
  5. Diabetes Res Clin Pract. 2019 Nov;157:107843 [PMID: 31518657]
  6. Sci Rep. 2022 Jul 26;12(1):12736 [PMID: 35882895]
  7. Lancet. 2020 Oct 17;396(10258):1160-1203 [PMID: 33069325]
  8. J Epidemiol Glob Health. 2024 Jun;14(2):379-397 [PMID: 38739356]
  9. Global Health. 2018 Nov 28;14(1):118 [PMID: 30486848]
  10. Diabetes Obes Metab. 2023 Nov;25(11):3390-3399 [PMID: 37589256]
  11. High Blood Press Cardiovasc Prev. 2014 Jun;21(2):81-7 [PMID: 24821373]
  12. Stroke. 2010 May;41(5):e418-26 [PMID: 20299666]
  13. Nutrients. 2024 Aug 09;16(16): [PMID: 39203759]
  14. Curr Cardiol Rep. 2024 Nov;26(11):1309-1320 [PMID: 39235729]
  15. Lancet Neurol. 2019 May;18(5):439-458 [PMID: 30871944]
  16. Lancet. 2020 Oct 17;396(10258):1204-1222 [PMID: 33069326]
  17. Postgrad Med. 2020 Nov;132(8):709-713 [PMID: 32500799]
  18. J Health Popul Nutr. 2024 Feb 29;43(1):33 [PMID: 38424593]
  19. Open Med (Wars). 2024 Apr 05;19(1):20240940 [PMID: 38584824]
  20. Lancet. 2020 Oct 17;396(10258):1223-1249 [PMID: 33069327]
  21. BMJ Glob Health. 2021 Sep;6(9): [PMID: 34593512]
  22. Lancet. 2021 Jul 3;398(10294):53-63 [PMID: 34217401]
  23. N Engl J Med. 2017 Jul 6;377(1):13-27 [PMID: 28604169]
  24. BMJ Open Diabetes Res Care. 2020 Jul;8(1): [PMID: 32719076]
  25. Nutr Metab Cardiovasc Dis. 2024 Sep;34(9):2065-2074 [PMID: 38866612]
  26. Neurointervention. 2021 Mar;16(1):9-19 [PMID: 33389919]
  27. Lancet. 2016 Dec 10;388(10062):e19-e23 [PMID: 27371184]
  28. Lancet Oncol. 2019 Sep;20(9):1211-1225 [PMID: 31371206]
  29. Am J Clin Nutr. 1994 Jul;60(1):23-8 [PMID: 8017333]
  30. Bull World Health Organ. 2016 Sep 1;94(9):634-634A [PMID: 27708464]
  31. Obesity (Silver Spring). 2010 Jun;18(6):1242-6 [PMID: 20150903]
  32. Lancet Neurol. 2021 Oct;20(10):795-820 [PMID: 34487721]
  33. PLoS Med. 2020 Jul 28;17(7):e1003198 [PMID: 32722671]

Word Cloud

Created with Highcharts 10.0.0burdendiseasestrokeBMIstudytrendstype2diabetesT2DMhighyearsDALYsbodymassindexChinamellitushypertensiveheartHHDattributable2019lifeanalysistemporalincreaseU-shapedtrendageBackground:Highsignificantriskfactornon-communicablediseaseshoweverimpactremainsunderstudiedaimedanalyze1990Methods:utilizeddataGlobalBurdenDiseasequantifyingliveddisabilityYLDslostYLLsdisability-adjustedJoinpointregressionemployeddetermineResults:revealeddistinctgender-specificMenexhibitedconsistentacrossthreeconditionsWomenshowednuancedpatterns:gradualriseinvertedtermsage-standardizedAge-specificdemonstratedpeaked70-74-yeargroupwhereasHHD-relatedcontinuedadvancingConclusions:findingsunderscoreneedtailoredobesitypreventionmanagementstrategiesChinesehealthcaresettingsemphasizingearlyscreeninginterventionparticularlymiddle-agedolderadultsTrendsChina:1990-2019hypertension

Similar Articles

Cited By